Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.41 |
| ▸ | RBP4 | P02753 | 5/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2J2 | P51589 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | SCD | O00767 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1739282 | 0.87 | EPHX2 (0.52) | EPHX2HMOX1RBP4CYP2C9CYP2J2 | |
| SCHEMBL4106966 | 0.84 | EPHX2 (0.44) | EPHX2HMOX1CYP2C9CYP2J2CYP2C19 | |
| SCHEMBL6123546 | 0.84 | EPHX2 (0.40) | EPHX2HMOX1RBP4 | |
| SCHEMBL5155703 | 0.83 | EPHX2 (0.57) | EPHX2HMOX1RBP4CYP2C9CYP2J2 | |
| SCHEMBL1740359 | 0.80 | EPHX2 (0.50) | EPHX2RBP4RIPK1FAAH | |
| SCHEMBL2995903 | 0.78 | GPR119 (0.51) | RBP4PDE10A | |
| SCHEMBL1936648 | 0.77 | GRM4 (0.38) | — | |
| SCHEMBL6123596 | 0.76 | EPHX2 (0.48) | EPHX2HMOX1CYP2C9CYP2J2CYP2C19 | |
| SCHEMBL1740375 | 0.75 | GRM5 (0.39) | RBP4KDM4E | |
| SCHEMBL14992804 | 0.74 | EPHX2 (0.46) | EPHX2CYP2C9CYP2J2RIPK1SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102292340-B | Amino-heterocyclic compounds used as pde9 inhibitors | PFIZER | 2015-05-06 | — | — | CN | disclosed |
| CN-102292340-A | Amino-heterocyclic compounds used as PDE9 inhibitors | — | 2011-12-21 | — | — | CN | disclosed |
| EP-2389382-A1 | Amino-heterocyclic compounds used as pde9 inhibitors | Pfizer Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-8041687-B2 | Dynamic generation of XML Schema for backend driven data validation | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-10-18 | — | — | US | disclosed |
| WO-2010084438-A1 | AMINO-HETEROCYCLIC COMPOUNDS USED AS PDE9 INHIBITORS | PFIZER INC. (US) | 2010-07-29 | — | — | WO | disclosed |